RT @doc_BLocke: @T_Allen1998 @VPrasadMDMPH @carlheneghan @JKAronson @MaartenvSmeden @statsepi I had the same thought... but it turns out al…
@T_Allen1998 @VPrasadMDMPH @carlheneghan @JKAronson @MaartenvSmeden @statsepi I had the same thought... but it turns out all cause still takes a larger sample to power even w higher rates - think noisier signal. Explained here: https://t.co/f8Rf83KWKL
Screening is not an unadulterated good. Politicians often mislead the public on this.... https://t.co/sMUKqeV3IG
Should we expect all-cause mortality reductions in large screening studies? https://t.co/h1K7vdqJ5N via @PublicHealthUGA @felly500 @SteveLaitner @janewilcock @VPrasadMDMPH
@mellojonny notable author on casue specific side stopped me dead (sic) I will read carefully this one is also good https://t.co/RG6B8JQkWS I don't wholly agree but still good even IF cause specific deemed ok, then rest of NSC criteria still need to be met
RT @BJGPjournal: Should we expect all-cause mortality reductions in large screening studies? the ACM/DSM ratio is a way to understand the d…
Should we expect all-cause mortality reductions in large screening studies? the ACM/DSM ratio is a way to understand the danger of overinterpreting ACM comparisons in studies powered to detect changes in DSM https://t.co/4hkO7o6auB
Should we expect all-cause mortality reductions in large screening studies? https://t.co/TC6zQrTGjK